CDKN2A and Huntington disease: It is important to note that this study is the first to formally assess CDKN2B HD in addition to CDKN2A HD and is one of only three studies in the Post-Molecular Characterisation Era to include both CDKN2A and CDKN2B deletions (see Table 2).